ovarian cancer

September 20, 2018

Chic Awearness event supports VUMC ovarian cancer research

The T.J. Martell Foundation’s 6th Annual Chic Awearness fundraising event that supports ovarian cancer research at Vanderbilt-Ingram Cancer Center will be held Monday, Sept. 24, 6:30 – 8:30 p.m.

By Tom Wilemon
September 13, 2017

Chic Awearness event supports VUMC ovarian cancer research

The annual Chic Awearness fundraising event that supports ovarian cancer research at major medical centers, including Vanderbilt University Medical Center (VUMC), will be held Monday, Sept. 25, 6:30 – 8:30 p.m., at Prima Restaurant, 700 12th Ave. South.

By VUMC News and Communications
iStock Photo
May 17, 2017

Blood type link to cancer survival

Blood type A was associated with longer ovarian cancer survival in a recent Vanderbilt-led study.

By Bill Snyder
March 14, 2017

VICC ovarian cancer funding opportunity

The Vanderbilt-Ingram Cancer Center (VICC) announces a funding opportunity to catalyze innovative, collaborative ovarian cancer-related projects.

By VUMC News and Communications
September 16, 2016

Know the facts about ovarian cancer

Listening to the body and being aware of individual risks are especially important when it comes to ovarian cancer. Vanderbilt–Ingram Cancer Center provides the facts.

By VUMC News and Communications
September 15, 2016

Fashion show to benefit VICC ovarian cancer research

Fall fashions for women will be on display during the 4th Annual Chic Awearness Fashion Show promoting ovarian cancer awareness and research. The event, to be held Monday, Sept. 26, 6:30 to 8:30 p.m., will benefit the T.J. Martell Foundation, which supports ovarian cancer research at Vanderbilt-Ingram Cancer Center (VICC).

By VUMC News and Communications
December 10, 2015

New lead for ovarian cancer treatment

Combining inhibitors of the BMP signaling pathway with standard chemotherapy drugs may overcome drug resistance in ovarian cancer.
By VUMC News and Communications
August 11, 2015

Drug combos enhance ovarian cancer cell death

Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities.
By Leigh MacMillan
January 21, 2014

VICC receives $100,000 ovarian cancer research grant

The Kay Yow Cancer Fund, in partnership with the Women’s Basketball Coaches Association and The V Foundation for Cancer Research, has awarded a $100,000 ovarian cancer research grant to the Vanderbilt-Ingram Cancer Center.
By VUMC News and Communications
November 13, 2013

Molecular circuits in ovarian cancer

Vanderbilt researchers have used bioinformatics analysis of gene expression data to describe molecular “circuits” that drive ovarian cancer.
By Leigh MacMillan
August 22, 2013

Overcoming resistance in ovarian cancer

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.
By Leigh MacMillan
April 18, 2013

Noted pediatric surgeon to deliver Brooks Lecture May 10

Renowned pediatric surgeon, scientist and Harvard Medical School’s first female professor of surgery Patricia K. Donahoe will address the Section of Surgical Sciences’ 55th Barney Brooks Lecture, Friday, May 10, at 7 a.m. in 208 Light Hall.
By VUMC News and Communications
December 24, 2012

A drug combo for ovarian cancer

Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer.
By Leigh MacMillan
1 2 3